Skip to main content
. 2015 Aug 4;6(35):38410–38420. doi: 10.18632/oncotarget.4800

Table 3. Prognostic factors for LRFS, DMFS, RFS and OS by multivariate Cox regression analysis in 255 ESCC patients.

LRFS DMFS RFS OS
HR (95% CI) P HR (95% CI) P HR (95% CI) P HR (95% CI) P
Differentiation (poorly/well and moderately) 0.987 (0.380–2.566) 0.979 1.469 (0.895–2.413) 0.128 1.381 (0.889–2.146) 0.151 1.834 (1.095–3.073) 0.021
Tumor length (>5 cm/≤5 cm) 0.925 (0.354–2.418) 0.874 1.364 (0.849–2.201) 0.204 1.301 (0.848–1.997) 0.228 1.961 (1.211–3.174) 0.006
T stage (T3–4/T1–2) 1.958 (0.819–4.679) 0.131 1.039 (0.636–1.700) 0.878 1.208 (0.785–1.860) 0.390 1.797 (0.989–3.264) 0.054
N stage (N+/N−) 1.995 (0.920–4.330) 0.081 1.592 (1.010–2.509) 0.045 1.740 (1.170–2.588) 0.006 1.997 (1.203–3.304) 0.007
Plasma fibrinogen levels (High/normal) 0.998 (0.479–2.077) 0.995 2.541 (1.615–4.001) <0.001 2.002 (1.360–2.946) <0.001 1.728 (1.070–2.793) 0.025

Bold values are statistically significant (P < 0.05).